Thomas G P, Stephen P M
Department of Pharmacology, Christian Medical College, Vellore, India.
Arch Int Pharmacodyn Ther. 1993 May-Jun;323:23-31.
Methyldopa (25, 50 and 100 mg/kg, i.p.) was studied for its effect on cardiac arrhythmias and lethality induced by slow intravenous infusion of ouabain in guinea-pigs. Methyldopa increased the dose of ouabain required to elicit the arrhythmic stages and lethality. However, it did not provide any protection in reserpinized guinea-pigs. Methyldopa also inhibited the rate of the ouabain-induced rise in blood pressure and the peak pressor response. Yohimbine significantly antagonized the protective action of methyldopa. It is concluded that the protective action of methyldopa against the arrhythmogenic and lethal effects of ouabain may be due to its action on the indirect neural components of ouabain toxicity, mediated through stimulation of alpha 2-adrenoceptors.
研究了甲基多巴(25、50和100毫克/千克,腹腔注射)对豚鼠缓慢静脉注射哇巴因所诱发的心律失常和致死率的影响。甲基多巴增加了诱发心律失常阶段和致死率所需的哇巴因剂量。然而,它对利血平化的豚鼠没有提供任何保护作用。甲基多巴还抑制了哇巴因诱导的血压升高速率和升压反应峰值。育亨宾显著拮抗甲基多巴的保护作用。得出结论,甲基多巴对哇巴因致心律失常和致死作用的保护作用可能是由于其对哇巴因毒性间接神经成分的作用,通过刺激α2肾上腺素能受体介导。